Helping people in treatment for opioid use disorder disclose their history

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial tests a disclosure intervention aimed at individuals undergoing treatment for opioid use disorder. Participants will engage in a brief intervention designed to facilitate key disclosures about their condition and enhance their skills in sharing this information. The effectiveness of this intervention will be evaluated by comparing treatment and recovery outcomes one year later with those of participants in a waitlist group who will receive the intervention after the study period. The goal is to determine if the intervention leads to improved social support and reduced stigma.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Client of Brandywine Counseling \& Community Services
* Receiving opioid use disorder treatment at Brandywine Counseling \& Community Services
* Considering disclosing one's opioid use disorder history and/or treatment to someone new

Exclusion Criteria:

* Diagnosis of schizophrenia
* Participation in pilot study of intervention

Where it's running

• Brandywine Counseling & Community Services
  Wilmington, Delaware, United States Recruiting

Study contacts

• Study coordinator: Valerie A Earnshaw, PhD
• Email: earnshaw@udel.edu
• Phone: 1-302-831-4772

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• Cebranopadol for opioid withdrawal in adults with chronic pain

  This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

  Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand

  This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT07800520

• STORC: Training a support person plus patient navigation after birth

  We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.

  Recruiting Friends Research Institute, Inc. · Philadelphia, Pennsylvania · NCT07787039

• Personalized Addiction Treatment Enhancement for Opioid Use Disorder

  A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.

  Recruiting Rhode Island Hospital · Providence, Rhode Island · NCT07778394

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.